HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Marc S Ernstoff Selected Research
Marc S Ernstoff Research Topics
Disease
73
Neoplasms (Cancer)
11/2021 - 05/2002
53
Melanoma (Melanoma, Malignant)
01/2022 - 03/2002
25
Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 09/2002
10
Neoplasm Metastasis (Metastasis)
08/2018 - 03/2002
7
Brain Neoplasms (Brain Tumor)
12/2021 - 10/2008
6
Colitis
12/2021 - 05/2012
6
Disease Progression
12/2021 - 05/2006
5
Glioblastoma (Glioblastoma Multiforme)
03/2017 - 04/2011
4
Exanthema (Rash)
09/2019 - 03/2010
4
Carcinoma (Carcinomatosis)
10/2018 - 04/2003
4
Prostatic Neoplasms (Prostate Cancer)
03/2013 - 05/2006
3
Cardiotoxicity
12/2021 - 10/2018
3
Diarrhea
11/2021 - 12/2010
3
Inflammation (Inflammations)
01/2021 - 01/2012
3
Fatigue
11/2018 - 03/2010
3
Kidney Neoplasms (Kidney Cancer)
06/2007 - 09/2006
3
Leukemia
09/2006 - 04/2003
2
Hypophysitis
12/2021 - 11/2016
2
Neurologic Manifestations (Neurological Manifestations)
11/2021 - 08/2018
2
Vitiligo
01/2021 - 05/2011
2
Myocarditis (Carditis)
01/2021 - 01/2019
2
Body Weight (Weight, Body)
08/2018 - 05/2015
2
Colorectal Neoplasms (Colorectal Cancer)
05/2018 - 11/2010
2
Nevus (Nevi)
12/2016 - 09/2002
2
Human Influenza (Influenza)
11/2008 - 05/2003
1
cell-associated neurotoxicity
12/2021
1
Cytokine Release Syndrome
12/2021
1
Meningioma (Meningiomas)
11/2021
1
Atrioventricular Block
01/2021
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1
Hematologic Neoplasms (Hematological Malignancy)
01/2021
Drug/Important Bio-Agent (IBA)
22
Interleukin-2 (IL2)
IBA
01/2020 - 01/2003
15
Cytokines
IBA
11/2018 - 04/2003
13
Immune Checkpoint Inhibitors
IBA
01/2021 - 01/2018
12
Vaccines
IBA
12/2020 - 03/2004
10
Nivolumab
IBA
12/2021 - 05/2015
9
Ipilimumab
IBA
12/2021 - 05/2012
8
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2006
7
Biomarkers (Surrogate Marker)
IBA
01/2021 - 12/2006
7
Peptides (Polypeptides)
IBA
12/2015 - 05/2003
6
pembrolizumab
IBA
01/2021 - 05/2018
6
Antigens
IBA
10/2020 - 04/2003
5
Temozolomide (Temodar)
FDA Link
Generic
03/2017 - 10/2008
5
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
12/2015 - 04/2003
5
Interferons
IBA
01/2012 - 03/2004
4
Vemurafenib
IBA
11/2020 - 04/2014
4
Ligands
IBA
10/2020 - 01/2017
4
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2017 - 02/2009
4
Sorafenib (BAY 43-9006)
FDA Link
01/2014 - 03/2007
4
Pharmaceutical Preparations
IBA
05/2012 - 12/2006
3
Alanine Transaminase (SGPT)
IBA
12/2021 - 11/2016
3
MicroRNAs (MicroRNA)
IBA
03/2019 - 01/2018
3
Sunitinib (Sutent)
FDA Link
03/2019 - 12/2011
3
HLA Antigens (Human Leukocyte Antigens)
IBA
12/2015 - 01/2006
3
aldesleukin (Proleukin)
FDA Link
02/2015 - 06/2007
3
Cancer Vaccines
IBA
03/2008 - 03/2004
3
Interferon alpha-2 (Roferon-A)
FDA Link
05/2007 - 03/2002
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
12/2021 - 11/2021
2
Steroids
IBA
11/2021 - 01/2021
2
Monoclonal Antibodies
IBA
01/2021 - 07/2008
2
Troponin I
IBA
01/2021 - 01/2019
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2021 - 01/2021
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2020 - 01/2016
2
Imatinib Mesylate (Gleevec)
FDA Link
11/2019 - 09/2013
2
pazopanib
FDA Link
03/2019 - 10/2018
2
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
11/2018 - 01/2016
2
Interleukin-15 (Interleukin 15)
IBA
11/2018 - 11/2009
2
Formaldehyde (Formol)
FDA Link
10/2018 - 01/2018
2
Paraffin
IBA
10/2018 - 01/2018
2
Gemcitabine
FDA Link
09/2017 - 09/2006
2
Mitogen-Activated Protein Kinases
IBA
01/2016 - 03/2007
2
Phosphotransferases (Kinase)
IBA
04/2014 - 03/2007
2
Platinum
IBA
04/2014 - 12/2006
2
interleukin-21 (interleukin 21)
IBA
01/2014 - 11/2009
2
Bevacizumab (Avastin)
FDA Link
11/2013 - 03/2010
2
Androgens
IBA
03/2013 - 12/2006
2
Prostate-Specific Antigen (Semenogelase)
IBA
09/2011 - 12/2006
2
Coloring Agents (Dyes)
IBA
11/2008 - 01/2007
2
Epitopes
IBA
07/2008 - 01/2006
2
Biological Products
IBA
09/2007 - 01/2003
2
DNA (Deoxyribonucleic Acid)
IBA
12/2006 - 09/2002
2
Interferon-alpha (Interferon Alfa)
IBA
01/2003 - 09/2002
1
tocilizumab (atlizumab)
FDA Link
12/2021
1
vedolizumab
IBA
11/2021
1
4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)
IBA
11/2021
1
Infliximab (Remicade)
FDA Link
11/2021
1
Thrombin
FDA Link
11/2021
1
Propranolol (Inderal)
FDA Link
Generic
01/2021
1
Indicators and Reagents (Reagents)
IBA
01/2021
1
Troponin
IBA
01/2021
1
RNA (Ribonucleic Acid)
IBA
01/2021
Therapy/Procedure
50
Therapeutics
01/2022 - 01/2003
25
Immunotherapy
01/2021 - 09/2005
6
Drug Therapy (Chemotherapy)
03/2013 - 12/2006
4
Radiotherapy
05/2011 - 03/2007
2
Precision Medicine
01/2021 - 01/2019
2
Aftercare (After-Treatment)
01/2016 - 11/2014
2
Injections
11/2010 - 03/2004
2
Biological Therapy
09/2007 - 03/2004
2
Drug Tapering
03/2007 - 09/2006